The prognostic value of expiratory carbon monoxide level for outcome prediction after myocardial infarction
- 7 October 2025
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (15) , 2760-2770
Abstract
Aims: To assess the prognostic value of expiratory carbon monoxide (CO) levels in patients admitted for myocardial infarction (MI). Methods and results: In this prospective study, expiratory CO levels were measured upon admission in consecutive patients hospitalized for MI across 39 centres. The primary outcome was 1-year all-cause death. Secondary outcomes included 1-year major adverse cardiac events (MACEs: cardiovascular death and recurrent MI) and in-hospital major adverse events (MAEs: death, severe ventricular arrhythmia, cardiogenic shock, and the need for mechanical ventilation). The prognostic value of expiratory CO levels was further evaluated using machine learning (ML) analysis. Among 717 patients (64 ± 13 years; 75% males; 33% active smokers; 43% ST-elevation MI), elevated expiratory CO levels (>11 ppm) were found in 79 patients (11%). Patients with elevated CO levels had a higher rate of 1-year all-cause mortality compared with those without (16.5% vs. 5.2%, P < 0.001). Elevated CO levels were independently associated with 1-year all-cause death across various adjustment models: comorbidities [odds ratio (95% confidence interval): 3.6 (1.7–7.5)], clinical parameters of in-hospital severity [4.5 (2.3–8.8)], and respiratory parameters [6.3 (3.1–12.8)]. Elevated CO levels were also independently associated with a significant increase in 1-year MACEs and in-hospital MAEs. Machine learning analysis identified CO level as one of the most important predictors of adverse events, compared with other known prognosticators. Conclusion: This is the first study to demonstrate that elevated expiratory CO levels upon admission are independently associated with an increased risk of 1-year all-cause mortality, 1-year MACEs, and in-hospital MAEs in patients hospitalized for MI.Keywords
Funding Information
- Coeur et Recherche
This publication has 25 references indexed in Scilit:
- Carbon monoxide and prognosis in smokers hospitalised with acute cardiac events: a multicentre, prospective cohort studyeClinicalMedicine, 2024
- Prevalence of psychoactive drug use in patients hospitalized for acute cardiac events: Rationale and design of the ADDICT-ICCU trial, from the Emergency and Acute Cardiovascular Care Working Group and the National College of Cardiologists in Training of the French Society of CardiologyArchives of Cardiovascular Diseases, 2022
- Meta-Analysis Comparing Outcomes of Smokers Versus Nonsmokers With Acute Coronary Syndrome Underwent Percutaneous Coronary InterventionThe American Journal of Cardiology, 2018
- Use of Expired Air Carbon Monoxide Testing in Clinical Tobacco Treatment SettingsChest, 2018
- Impact of Pre-Procedural Cardiopulmonary Instability in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial)The American Journal of Cardiology, 2014
- Assessment of smoking behaviour in the dental setting. A study comparing self-reported questionnaire data and exhaled carbon monoxide levelsClinical Oral Investigations, 2011
- Carboxyhemoglobin levels in carbon monoxide poisoning: do they correlate with the clinical picture?The American Journal of Emergency Medicine, 2008
- Predictors of Hospital Mortality in the Global Registry of Acute Coronary EventsArchives of internal medicine (1960), 2003
- Influence of carbon monoxide (CO) on the early course of acute myocardial infarctionIntensive Care Medicine, 1995
- Carbon monoxide levels in cardiac patients in an urban emergency departmentThe American Journal of Emergency Medicine, 1986